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Background: Tenascin-C, a member of extra-cellular matrix protein, is detected in venous blood of patients with various cardiac diseases including 
myocardial infarction, myocarditis, cardiomyopathy and hypertensive heart disease. Recent studies have demonstrated that circulating tenascin-C 
level is a useful biomarker not only for cardiac remodeling but also for local inflammation. On the other hand, it has been widely recognized that 
coronary arterial calcification is a risk factor of cardiovascular diseases. The purpose of the present study was to examine whether high serum levels 
of tenascin-C were associated with coronary arterial calcification in patients with stable effort angina pectoris (EAP). 
Methods: Consecutive 40 EAP patients who underwent PCI were examined. Blood samples were obtained from ascending aorta just before the PCI 
procedures, and serum tenascin-C level was measured by ELISA. After crossing of a coronary guide wire to the target vessel, IVUS observations were 
performed for assessment of coronary arterial calcification. To grade the severity of coronary arterial calcification, patients were assigned to three 
groups according to the angle of coronary arterial calcification at the lesions estimated with IVUS (Group A: over 180 degrees, B: from 90 to 180 
degrees and C: less than 90 degrees). 
Results: There were 12 patients in group A, 11 patients in group B, and 17 patients in group C. There were no significant differences in the clinical 
characteristics among the three groups. Serum level of tenascin-C was significantly higher in the group A than in the group C (64.5±13.1 vs. 
36.2±3.9 ng/ml, P<0.05), indicating the linkage between coronary arterial calcification and circulating tenascin-C level. There were no significant 
differences in levels of high sensitive (hs)-CRP, hs-troponin T, triglyceride, HDL and LDL-cholesterol among the three groups. 
Conclusions: Our data demonstrate that circulating tenascin-C level is related to the degree of calcification in coronary artery lesions, suggesting 
that serum tenascin-C level is a novel biomarker for coronary arterial calcification in patient with stable effort angina pectoris.
